Cellular combat wound initiative
Ended Definitive Contract Awarded Last action
- Contract number
- N6264512C4009
- Awardee
-
Noveome Biotherapeutics Inc. UEI D35WXDLB8K59
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $8,499,954
Award facts
- Contract value 100% obligated
- $8,499,954.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Pittsburgh, PA 15219, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3 | |
| Change Order | $0 | |
| Change Order | $152,963 | |
| Original award | $8,346,994 |
Quick answers
Who was awarded contract N6264512C4009?
N6264512C4009 was awarded to Noveome Biotherapeutics Inc. by Bureau of Medicine and Surgery (Department of the Navy) on February 2, 2012.
How much is contract N6264512C4009 worth?
The government has obligated $8,499,954 on N6264512C4009.
Was contract N6264512C4009 competed?
The extent of competition for N6264512C4009 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award